Jacqueline E Paramarta

Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial

Dominique Baeten, Xenofon Baraliakos, Jürgen Braun et al. · The Lancet · 2013 · 590 citations

Medicine, Clinical Sciences, Immunology +14

Anti-TNF treatment blocks the induction of T cell-dependent humoral responses

Gabriela Salinas, Leen De Rycke, Barbara H. Barendregt et al. · Annals of the Rheumatic Diseases · 2012 · 117 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Calprotectin (S100A8/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritis

M. Turina, Nataliya Yeremenko, Jacqueline E Paramarta et al. · Arthritis Research & Therapy · 2014 · 83 citations · Full text

Medicine, Clinical Sciences, Immunology +16

Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis

Jacqueline E Paramarta, Leen De Rycke, Tanja F Heijda et al. · Annals of the Rheumatic Diseases · 2012 · 67 citations

Medicine, Pharmacotherapy, Hypersensitivity +15

Peripheral disease contributes significantly to the level of disease activity in axial spondyloarthritis

Janneke J. de Winter, Jacqueline E Paramarta, Henriëtte M. de Jong et al. · RMD Open · 2019 · 67 citations · Full text

Medicine, Internal Medicine, Orthopedics +9